medigraphic.com
ISSN 0016-3813 (Print)

2009, Number 3

<< Back Next >>

Gac Med Mex 2009; 145 (3)

Manifestaciones clínicas inusuales del hiperparatiroidismo primario

Reséndiz-Colosia JA, Rodríguez-Cuevas SA, Medrano-Ortiz ZME, Flores-Díaz R, Gallegos-Hernández JF, Gómez-Acosta F

Language: Spanish
References: 38
Page: 207-213
PDF size: 136.03 Kb.


ABSTRACT

Background: A growing number of patients with primary hyperparathyroidism (PHPT) are diagnosed in the absence of symptoms following routine biochemical screening. However, in some countries, overt manifestations and osteitis fibrosa cystica (OFC) still dominate the clinical profile of PHPT patients.
Methods: We retrospectively studied clinical and biochemical manifestations of 47 consecutive patients with primary hyperparathyroidism who were treated with parathyroidectomy from October 1993 to June 2005.
Results: Mean age was of 51.3 years. Our sample included 40 women (85%) and 7 men (15%). Seventy eight percent of cases had radiological features of OFC, namely subperiosteal bone resorption, cortical cysts and osteopenia. Pathological fracture occurred in nine patients (19.1%). Fifteen (32%) patients had clinically evident bony deformities or brown tumors mostly located in the mandible and maxilla.
Conclusions: Our results indicate that symptomatic osteitis fibrosa cystica and severe decrease of bone mineral density were the primary manifestations of primary hyperparathyroidism. Most patients were referred to an oncology hospital for treatment due to a suspected malignant neoplasm. A comprehensive clinical evaluation with biochemical markers, imaging studies and histological results is needed to establish a possible diagnosis of primary hyperparathyroidism.


REFERENCES

  1. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023-1029.

  2. Irvin G, Carneiro D. Management changes in primary hyperparathyroidism. JAMA 2000;8:934-936.

  3. Pruhs ZM, Starling JR, Mack E Chen H. Changing trends for surgery in elderly patients with hyperparathyroidism at a single institution. J Surg Res 2005;127:59-62.

  4. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005;90:1525-1530.

  5. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversy in primary hyperparathyroidism. J Clin Endocrin Metabol 1999;84:2275-2285.

  6. Walgenbach S, Hommel G, Junginger T. Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 2000;24:564-570.

  7. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980;302:189-193.

  8. Soreide JA, van Heerden JA, Grant CS, Lo CY. Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal disease. Surgery 1996;120:1033-1037.

  9. Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J. Do the National Institutes of Health Consensus Guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 2002;132:1013-1020.

  10. Hasse C, Sitter H, Bachmann Z, Zielke A, Koller M, Nies C. How asymptomatic is asymptomatic primary hyperparathyroidism? Exp Clin Endocrinol Diabetes 2000;108:265-274.

  11. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J. A patients-based surgical outcome tool demonstrating improvement of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 2002;26:942-949.

  12. Chan AK, Duh Q, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. Ann Surg 1995;222:1-12.

  13. Mendoza V, Zamudio JF, Peña JF, Marín A, Martínez E, Mercado M. Hiperparatiroidismo primario, reporte de 67 casos. Experiencia de los últimos cinco años en el Hospital de Especialidades, Centro Médico Nacional Siglo XXI. Cir Ciruj 2003;71:363-368.

  14. Delgadillo GH, Fenig J, González F, Velásquez JA, Serrano I, Bevia F. Experiencia de 15 años en el tratamiento quirúrgico del hiperparatiroidismo. Cir Gen 2005;27:149-151.

  15. Pino V, Yánez TK, Ruiz GT, García MM, Pardo G, Blasco A. Evolución clínica en los pacientes intervenidos por hiperparatiroidismo primario. Nuestros resultados y revisión de la literatura. Acta Otorrinolaringol Esp 2003;54:584-588.

  16. Raeburn CD, Cothren C, McIntyre RC. End-stage manifestations of severe hyperparathyroidism. Surgery 2002;131:896-898.

  17. Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rasted J. Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg 2001;88:708-714.

  18. Onur M, Seymen H, Kadioglo A. Intense skeletal lesions in a patient with primary hyperparathyroidism disease. Clin Nucl Med 2001;26:727-728.

  19. Agarwal G, Mishra S, Kar D, Singh AK, Arya V, Gupta S, et al. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 2002;132:1075-1085.

  20. Pai M, Park CH, Kim BS, Chung YS, Park A, Hee B. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med 1997;22:691-694.

  21. Yamazaky H, Ota Y, Auki T, Katakida K. Brown tumor of the maxilla and mandible: Progressive mandibular brown tumor after removal of parathyroid adenoma. J Oral Maxillofac Surg 2003;61:719-722.

  22. Rubin MR, Livolsi VA, Bandeira F, Caldas G, Bilezikian JP. Tc99m- sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease. J Clin Endocrinol Metab 2001;86:5138-5141.

  23. Kar DK, Gupta SK, Agarwal A, Mishra SK. Brown tumor of the palate and mandible in association with primary hyperparathyroidism. J Oral Maxillofac Surg 2001;59:1352-1354.

  24. Morgan G, Ganapathi M, Afzal S, Grant AJ. Pathological fracture in primary hyperparathyroidism. A case report highlighting diagnostic difficulties. Int J Care Injured 2002;33:288-291.

  25. Caglar M, Naldoken S. Multiple brown tumors simulating bone metastases. A case of parathyroid adenoma coexisting with papillary carcinoma of the thyroid. Clin Nucl Med 2000;25:772-774.

  26. Coker LH, Rorie K, Cantley L, Kirklsnd K, Stump D, Burnank N. Primary hyperparathyroidism, cognition and health-related quality of life. Ann Surg 2005;242:642-650.

  27. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potencial economic impact in a community. N Engl J Med 1980;302:189.

  28. Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: Do the benefits outweigh the risks? World J Surg 1998;22:531-536.

  29. Khosla S, Melton LJ III, Wermers RA, Crowson SC, O’Fallon, Riggs B. Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res 1999;14:1700-1707.

  30. Eisenbud L, Stern M, Rothberg M, Sachs SA. Central giant cell granuloma of the jaws: Experiences in the management of thirty-seven cases. J Oral Maxillofac Surg 1988;36:375-384.

  31. Whitaker SB, Waldron CA. Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 1993;75:199-208.

  32. Carlos R, Sedano HO. Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol 2002;93:161-166.

  33. Crestanello JP, Fernández C, Robano A. Corticoides intralesionales en lesiones de células gigantes. Rev Esp Oral y Maxillofac 2004;25:351-360.

  34. Lietman SA, Levine MA. Resolution of giant cell granuloma after treatment with calcotonin. Oral Oncology EXTRA 2005;41:125-127.

  35. Edwards PC, Fox J, Fantasia JE, Goldberg J, Kelsch RD. Bilateral central giant granuloma of the mandible in an 8-years-old girl with Noonan syndrome (Noonan-like/multiple giant cell lesion syndrome). Pathol Oral Radiol Endod 2005;99:334-340.

  36. Taylor KF, Yingsakmongkol W, Conard KA, Stanton RP. Multicentric giant cell tumor of bone: a case report and review of the literature. Clin Orthop 2003;410:267-273.

  37. Cummins CA, Scarborough MT, Enneking WF. Multicentric giant cell tumor of bone. Clin Orthop 1996;322:245-252.

  38. Mendenhall WM, Zlorecki RA, Scarborough MT, Gibbs CP, Mendenhall NP. Giant cell tumor of bone. Am J Clin Oncol 2006;29:96-99.




2020     |     www.medigraphic.com